| P50 | author | Oscar Arrieta | Q61114456 |
| | Carmen Balaña | Q47164054 |
| P2093 | author name string | Sonia Bermúdez | |
| | Andrés F Cardona | |
| | Leonardo Rojas | |
| | Juan Fernando Ramón | |
| | Diego Pineda | |
| | Enrique Jiménez | |
| | Nicolás Useche | |
| | Alejandro Ruiz-Patiño | |
| | Fernando Hakim | |
| | Juan Armando Mejía | |
| | Zyanya Lucia Zatarain-Barrón | |
| | Luisa Ricaurte | |
| | Luis Eduardo Pino | |
| | Hernando Cifuentes | |
| P2860 | cites work | Combined treatment by octreotide and everolimus: Octreotide enhances inhibitory effect of everolimus in aggressive meningiomas. | Q52940698 |
| | Recurrent high-grade meningioma: a phase II trial with somatostatin analogue therapy | Q60547017 |
| | Immunohistochemical study of Ki-67 (MIB-1), p53 protein, p21WAF1, and p27KIP1 expression in benign, atypical, and anaplastic meningiomas | Q74538939 |
| | Recurrent meningioma: salvage therapy with long-acting somatostatin analogue | Q81039249 |
| | Meningiomas: Overview and New Directions in Therapy | Q88081751 |
| | Meningiomas: knowledge base, treatment outcomes, and uncertainties. A RANO review | Q30356126 |
| | Phase II trial of sunitinib for recurrent and progressive atypical and anaplastic meningioma. | Q30361848 |
| | CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012. | Q30373363 |
| | Historical benchmarks for medical therapy trials in surgery- and radiation-refractory meningioma: a RANO review | Q30393860 |
| | Intracranial meningiomas, the VEGF-A pathway, and peritumoral brain oedema | Q30621959 |
| | Epidemiology and etiology of meningioma | Q34154936 |
| | Phase II study of monthly pasireotide LAR (SOM230C) for recurrent or progressive meningioma | Q35106253 |
| | Expression of somatostatin receptors (SSTR1-SSTR5) in meningiomas and its clinicopathological significance | Q36375359 |
| | EANO guidelines for the diagnosis and treatment of meningiomas | Q38823997 |
| | The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary | Q38829244 |
| | "Malignancy" in meningiomas: a clinicopathologic study of 116 patients, with grading implications | Q48222606 |
| | Meningioma grading: an analysis of histologic parameters | Q48574941 |
| | Systemic therapy for recurrent meningioma | Q48787594 |
| | Hitting a moving target: evolution of a treatment paradigm for atypical meningiomas amid changing diagnostic criteria. | Q51116319 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 6 | |
| P304 | page(s) | e0217340 | |
| P577 | publication date | 2019-06-20 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Systemic management of malignant meningiomas: A comparative survival and molecular marker analysis between Octreotide in combination with Everolimus and Sunitinib | |
| P478 | volume | 14 | |